Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Change in Intangibles (2016 - 2025)

Lexaria Bioscience's Change in Intangibles history spans 10 years, with the latest figure at $5099.0 for Q4 2025.

  • For Q4 2025, Change in Intangibles fell 61.25% year-over-year to $5099.0; the TTM value through Nov 2025 reached $59441.0, down 49.93%, while the annual FY2025 figure was $75106.0, 48.41% down from the prior year.
  • Change in Intangibles for Q4 2025 was $5099.0 at Lexaria Bioscience, down from $14610.0 in the prior quarter.
  • Across five years, Change in Intangibles topped out at $70727.0 in Q2 2021 and bottomed at $2991.0 in Q1 2021.
  • The 5-year median for Change in Intangibles is $26573.0 (2024), against an average of $30558.1.
  • The largest annual shift saw Change in Intangibles skyrocketed 299000.0% in 2021 before it tumbled 67.12% in 2024.
  • A 5-year view of Change in Intangibles shows it stood at $15840.0 in 2021, then fell by 9.46% to $14342.0 in 2022, then surged by 179.08% to $40026.0 in 2023, then tumbled by 67.12% to $13159.0 in 2024, then crashed by 61.25% to $5099.0 in 2025.
  • Per Business Quant, the three most recent readings for LEXX's Change in Intangibles are $5099.0 (Q4 2025), $14610.0 (Q3 2025), and $13159.0 (Q4 2024).